Newly Diagnosed High Risk B-Precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine

Children's Oncology Group (COG)


Clinical Trial

Offered by: Nemours
Locations: Delaware Valley, Jacksonville, FL, Orlando, FL, Pensacola, FL

Trial Name

A Phase III Randomized Trial for Newly Diagnosed High Risk B-Precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum

What is the trial about?

Collect information about child's leukemia and about the effects of the first phase of treatment called Induction.

Who can participate?

> 1 year of age and < 31 years of age.

What is involved?

Induction treatment will last 4 weeks. In addition to standard cancer care treatment, the following tests will be performed: Fluorescence In Situ Hybridization (FISH); Minimal Residual Disease (MRD); Hypodiploidy.

Contact Nemours Clinical Trials

Trial Name: A Phase III Randomized Trial for Newly Diagnosed High Risk B-Precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum

COG#: AALL1131

Contact Information

(800) 354-5690
clinicaltrials@nemours.org